Reclaiming missed opportunities: a strategy of targeted direct-acting antiviral prophylaxis for HCV-seronegative recipients of HCV-seropositive donor kidneys

被引:2
|
作者
Durand, Christine M. [1 ]
Garonzik-Wang, Jacqueline [2 ]
Desai, Niraj M. [2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
关键词
HEPATITIS-C VIRUS; TRANSPLANTATION;
D O I
10.1111/tri.13433
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:690 / 692
页数:3
相关论文
共 41 条
  • [1] Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients
    Aqel, Bashar
    Wijarnpreecha, Karn
    Pungpapong, Surakit
    Taner, C. Burcin
    Reddy, Kunam
    Leise, Michael
    Mi, Lanyu
    Dickson, Rolland C.
    JOURNAL OF HEPATOLOGY, 2021, 74 (04) : 873 - 880
  • [2] MULTICENTER EXPERIENCE EVALUATING OUTCOMES OF HCV-SEROPOSITIVE DONORS TO HCV-SERONEGATIVE RECIPIENTS LIVER TRANSPLANTATION
    Wijarnpreecha, Karn
    Aqel, Bashar A.
    Pungpapong, Surakit
    Taner, Burcin
    Reddy, Kunam S.
    Leise, Michael D.
    Dickson, Rolland
    HEPATOLOGY, 2019, 70 : 2A - 2A
  • [3] Multicenter experience evaluating outcomes of HCV-seropositive donors to HCV-seronegative recipients liver transplantation
    Wijarnpreecha, Karn
    Pungpapong, Surakit
    Bashar, Aqel
    Reddy, Kunam
    Taner, Burcin
    Leise, Michael
    Dickson, Rolland
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E572 - E573
  • [4] Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
    Kapila, Nikhil
    Al Khalloufi, Kawtar
    Flocco, Gianina
    Menon, K. V. Narayanan
    Lindenmeyer, Christina
    Reino, Diego
    Vanatta, Jason M.
    Ebaid, Samer
    Tzakis, Andreas
    Zervos, Xaralambos Bobby
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (02) : 122 - 126
  • [5] Prophylaxis of HCV reinfection and direct-acting antiviral agents during liver transplantation
    Tavio, Marcello
    Vivarelli, Marco
    Menzo, Stefano
    Gori, Andrea
    Grossi, Paolo Antonio
    Marigliano, Anna
    LIVER TRANSPLANTATION, 2015, 21 (10) : 1327 - 1329
  • [6] Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
    Armando, Calogero
    Evangelista, Sagnelli
    Massimiliano, Creta
    Silvia, Angeletti
    Gaia, Peluso
    Paola, Incollingo
    Maria, Candida
    Gianluca, Minieri
    Nicola, Carlomagno
    Anna, Dodaro Concetta
    Massimo, Ciccozzi
    Caterina, Sagnelli
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [7] Prophylaxis of HCV Reinfection and Direct-acting Antiviral Agents During Liver Transplantation Reply
    Gutierrez, Julio A.
    Carrion, Andres
    Bhamidimarri, Kalyan Ram
    Peyton, Adam L.
    LIVER TRANSPLANTATION, 2015, 21 (10) : 1330 - 1330
  • [8] Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy
    Bowring, Mary G.
    Kucirka, Lauren M.
    Massie, Allan B.
    Ishaque, Tanveen
    Bae, Sunjae
    Shaffer, Ashton A.
    Wang, Jacqueline Garonzik
    Sulkowski, Mark
    Desai, Niraj
    Segev, Dorry L.
    Durand, Christine M.
    TRANSPLANTATION, 2018, 102 (12) : 2088 - 2095
  • [9] Transplantation of HCV Positive Kidneys into HCV Positive Recipients Followed By Early Direct Acting Antiviral Therapy: Is Ribavirin Necessary?
    Kapila, Nikhil
    Flocco, Gianina
    Al Khalloufi, Kawtar
    Zervos, Xaralambos Bobby
    HEPATOLOGY, 2018, 68 : 391A - 391A
  • [10] Deferred direct-acting antiviral treatment in kidney transplantation from HCV-viremic donors into HCV-negative recipients
    Pagano, Giulia
    Sola, Eulalia
    Canete, Nuria
    Broquetas, Teresa
    Carrion, Jose A.
    Puigvehi, Marc
    Coll, Susanna
    Garrido, Esther
    Viu, Ana
    Romero, Judit
    Jose Perez, Maria
    Zapatero, Ana
    Bessa, Xavier
    Crespo Barrio, Marta
    Garcia-Retortillo, Montserrat
    JOURNAL OF HEPATOLOGY, 2021, 75 : S799 - S799